Observational study reveals the influence of polygenic risk scores on colorectal cancer in various onset types, suggesting the need for larger studies.
PRS most strongly influences CRC risk in unexplained EOS- and F-CRC. The effect in LS individuals strongly depends on the penetrance of the altered gene and study design. Non-significant trends can partly be explained by the sample size of subgroups. Larger collaborative, prospective studies are needed to validate PRS for personalized CRC risk stratification.
No takes yet. Share an insight, caveat, or question.
Klinkhammer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: